Necroptosis Does Not Drive Disease Pathogenesis in a Mouse Infective Model of SARS-CoV-2 in Vivo
Overview
Authors
Affiliations
Necroptosis, a type of lytic cell death executed by the pseudokinase Mixed Lineage Kinase Domain-Like (MLKL) has been implicated in the detrimental inflammation caused by SARS-CoV-2 infection. We minimally and extensively passaged a single clinical SARS-CoV-2 isolate to create models of mild and severe disease in mice allowing us to dissect the role of necroptosis in SARS-CoV-2 disease pathogenesis. We infected wild-type and MLKL-deficient mice and found no significant differences in viral loads or lung pathology. In our model of severe COVID-19, MLKL-deficiency did not alter the host response, ameliorate weight loss, diminish systemic pro-inflammatory cytokines levels, or prevent lethality in aged animals. Our in vivo models indicate that necroptosis is dispensable in the pathogenesis of mild and severe COVID-19.
Cheng L, Rui Y, Wang Y, Chen S, Su J, Yu X J Biomed Sci. 2024; 31(1):70.
PMID: 39003473 PMC: 11245872. DOI: 10.1186/s12929-024-01062-1.
The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo.
Kelepouras K, Saggau J, Varanda A, Zrilic M, Kiefer C, Rakhsh-Khorshid H Cell Death Differ. 2024; 31(7):897-909.
PMID: 38783091 PMC: 11239901. DOI: 10.1038/s41418-024-01313-6.
Blocking cell death limits lung damage and inflammation from influenza.
Gupta N, Silke J Nature. 2024; 628(8009):726-727.
PMID: 38600194 DOI: 10.1038/d41586-024-00910-2.
Baker P, Bohrer A, Castro E, Amaral E, Snow-Smith M, Torres-Juarez F bioRxiv. 2024; .
PMID: 38585846 PMC: 10996686. DOI: 10.1101/2024.03.27.586885.